- Home
- CISO vs PRPO Comparison
CISO vs PRPO Comparison
Compare CISO & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- PRPO
- Stock Information
- Founded
- CISO 2015
- PRPO N/A
- Country
- CISO United States
- PRPO United States
- Employees
- CISO N/A
- PRPO N/A
- Industry
- CISO Computer Software: Prepackaged Software
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- CISO Technology
- PRPO Industrials
- Exchange
- CISO Nasdaq
- PRPO Nasdaq
- Market Cap
- CISO 31.4M
- PRPO 30.2M
- IPO Year
- CISO N/A
- PRPO N/A
- Fundamental
- Price
- CISO $1.05
- PRPO $20.47
- Analyst Decision
- CISO
- PRPO
- Analyst Count
- CISO 0
- PRPO 0
- Target Price
- CISO N/A
- PRPO N/A
- AVG Volume (30 Days)
- CISO 805.2K
- PRPO 15.2K
- Earning Date
- CISO 11-17-2025
- PRPO 11-06-2025
- Dividend Yield
- CISO N/A
- PRPO N/A
- EPS Growth
- CISO N/A
- PRPO N/A
- EPS
- CISO N/A
- PRPO N/A
- Revenue
- CISO $28,792,765.00
- PRPO $21,242,000.00
- Revenue This Year
- CISO N/A
- PRPO N/A
- Revenue Next Year
- CISO N/A
- PRPO N/A
- P/E Ratio
- CISO N/A
- PRPO N/A
- Revenue Growth
- CISO N/A
- PRPO 27.05
- 52 Week Low
- CISO $0.30
- PRPO $3.90
- 52 Week High
- CISO $3.84
- PRPO $22.38
- Technical
- Relative Strength Index (RSI)
- CISO 42.01
- PRPO 56.30
- Support Level
- CISO $1.16
- PRPO $16.40
- Resistance Level
- CISO $1.29
- PRPO $21.67
- Average True Range (ATR)
- CISO 0.12
- PRPO 1.43
- MACD
- CISO -0.02
- PRPO 0.05
- Stochastic Oscillator
- CISO 2.27
- PRPO 72.68
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.